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Major depressive disorder (MDD) is one of the most debilitating psychiatric diseases, affecting a large
percentage of the population worldwide. Currently, the underlying pathomechanisms remain incom-
pletely understood, hampering the development of critically needed alternative therapeutic strategies,
which further largely depends on the availability of suitable model systems.
Here we used a mouse model of early life stress e a precipitating factor for the development of MDD e
featuring infectious stress through maternal immune activation (MIA) by polyinosinic:polycytidilic acid
(Poly(I:C)) to examine epigenetic modulations as potential molecular correlates of the alterations in brain
structure, function and behavior. We found that in adult female MIA offspring anhedonic behavior was
associated with modulations of the global histone acetylation proﬁle in the hippocampus. Morevoer,
speciﬁc changes at the promoter and in the expression of the serotonin transporter (SERT), critically
involved in the etiology of MDD and pharmacological antidepressant treatment were detected.
Furthermore, an accompanying reduction in hippocampal levels of histone deacetylase (HDAC) 1 was
observed in MIA as compared to control offspring.
Based on these results we propose a model in which the long-lasting impact of MIA on depression-like
behavior and associated molecular and cellular aberrations in the offspring is brought about by the
modulation of epigenetic processes and consequent enduring changes in gene expression. These data
provide additional insights into the principles underlying the impact of early infectious stress on the
development of MDD and may contribute to the development of new targets for antidepressant therapy.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Major depressive disorder (MDD) is a highly prevalent psychi-
atric disorder affecting an estimated 10e15% of the population
worldwide (Bromet et al., 2011). It is characterized by the persistent
presence of several emotional, psychological and somatic symp-
toms including, but not limited to depressed mood, anhedonia,
fatigue, sleep disturbances, cognitive dysfunctions and suicidal
ideation (American Psychiatric, 2013). In most developed and high-ysiology and Neuropharma-
edical University of Vienna,
(D.D. Pollak).
Inc. This is an open access article uincome countries, MDD has thus consistently been ranked among
the top ﬁve public health issues with regard to socioeconomic
burden (Murray et al., 2012).
Akin to other neuropsychiatric illnesses, the currently available
therapeutic interventions for MDD exhibit several unfavorable
factors, limiting treatment success. Among these are the poorly
understood latency in the onset of the clinical effect of most
commonly used antidepressant medications, a high incidence of
adverse side effects and the considerable amount of non-
responders among the affected MDD patients (Holtzheimer and
Mayberg, 2011; Whiskey and Taylor, 2013). Furthermore, the het-
erogeneity and complexity of the disorder suggest a complex set of
interactions between several endogenous and exogenous variables
contributing to the pathogenesis of MDD, the underlying mecha-
nisms of which still remain poorly understood. Elucidation of thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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constitutes a prerequisite for the development of alternative ther-
apeutic strategies and is largely dependent on the availability of
speciﬁc animal models. Considering the relevance of chronic stress
as a precipitating factor for the development of MDD (Bagot et al.,
2014; Slavich and Irwin, 2014), several stress-based animal
models of depression exist, featuring paradigms of stress exposure
at various stages of life, including the prenatal period (Hammels
et al., 2015 Markham and Koenig, 2011; Meyer, 2014). Animal
models of prenatal infectious stress have recently been emerging as
powerful tools allowing to test the role of early immune stimulation
as a priming factor that induces long-lasting neuronal changes
contributing to the emergence of depression later in life (Reisinger
et al., 2015). One frequently used rodent model of maternal im-
mune activation (MIA) is based upon the systemic administration of
polyinosinic:polycytidilic acid (Poly(I:C)), a synthetic analog of
double-stranded RNA (dsRNA) and activator of toll-like receptor
(TLR) 3 (Tatematsu et al., 2014), to the pregnant dam in order to
mimic a gestational viral infection (Meyer, 2014 Reisinger et al.,
2015; Smith et al., 2007). Using this model, we have recently
demonstrated behavioral, neural and molecular alterations associ-
ated with depression in the adult male offspring (Khan et al., 2014).
Here we employed the Poly(I:C) MIA model to test the hypothesis
that the long-lasting nature of the impact of prenatal infectious
stress on brain structure and function, at the molecular, cellular and
behavioral levels, is associated with a modulation of epigenetic
mechanisms, central mediators of the impact of environmental
inﬂuences on brain and behavior (Bagot et al., 2014; Tsankova et al.,
2007). In addition to examining the consequence of MIA on key
elements of epigenetic regulation globally in the hippocampus, a
pivotal brain region in the neural circuitry of depression (McKinnon
et al., 2009; Posener et al., 2003), we speciﬁcally investigated its
effect on the serotonin transporter (SERT) - critically involved in the
etiology of MDD and pharmacological antidepressant treatment .
2. Materials and methods
2.1. Animals
All mice used were C57BL/6N mice obtained from Charles River
(Sulzfeld, Germany). Behavioral and molecular experiments were
carried out in separate cohorts of adult female offspring (8e12
weeks) from maternal immune activation at embryonic day 12.5
(PIC) and age matched control animals. A diagram depicting the
time course and experimental design of this study is provided in
Fig. 1.
Animals were housed under standard conditions, all animal
procedures were approved by the national ethical committee on
animal care and use in Austria (Bundesministerium für Wissen-
schaft und Forschung: BMWF-66.009/0015-II/3b/2012) and were
carried out according to international laws and policies. All efforts
were made to minimize animal suffering and discomfort and to
reduce the number of animals used.
2.2. Timed mating and maternal immune activation
Timed mating procedures were carried out following an estab-
lished protocol, as previously described (Khan et al., 2014). Upon
conﬁrmation of a vaginal plug in the morning following the mating
period, this time was denoted as embryonic day 0.5 (E0.5) (Simard
et al., 2010).
On E12.5 the total weight gain (%) since mating was calculated
for each dam. C57BL/6 mice can be expected to gain 25%e40% of
their initial body weight during the ﬁrst 12.5 days of pregnancy,
allowing the determination of pregnancy with up to 99% certaintyat this time point (Hau and Skovgaard Jensen, 1987). Pregnant mice
were subjected to either MIA or control treatment at E12.5, since
the effect of Poly(I:C)-induced MIA on depression-related behavior
and associated neurobiological changes in mice has been previ-
ously described at this time point (Khan et al., 2014).
For MIA, pregnant mice were injected intraperitoneally (i.p.)
with 20mg/kg Poly(I:C) (Polyinosinicepolycytidylic acid potassium
salt, Sigma Aldrich, St. Louis, MO, USA) dissolved in vehicle or the
vehicle alone (physiological saline solution, 0.9%, Fresenius Kabi,
Bad Homburg, Germany). The injection volume for both conditions
was 10 ml/kg.2.3. Behavioral testing
All behavioral experiments were carried out during the light
phase of the light-dark cycle.2.3.1. Sucrose preference test (SPT)
The experimental protocol used has been previously described
in detail (Savalli et al., 2015). Brieﬂy, mice were food and water
restricted for 18 h prior to a two-bottle forced choice test (regular
drinking water vs 2% sucrose (Sigma Aldrich, St. Louis, MO, USA)
solution) conducted over a 3 h testing period. The consumption of
sucrose solution relative to the total liquid consumption was eval-
uated and the percentage of sucrose preference calculated from this
measure.2.3.2. Forced swim test (FST)
The forced swim test was carried out as previously described
(Khan et al., 2014; Monje et al., 2011). Brieﬂy, mice were placed into
glass beakers ﬁlled with tap water (~22 C) for 6min. Their mobility
was recorded and automatically analyzed using the software Vid-
eotrack (Viewpoint, Champagne au Mont d'Or, France) for the
evaluation of the proportion of time spent immobile during the last
4 min of the test.2.3.3. Elevated plus maze (EPM)
For the EPM test, mice were placed in the center of a plus-
shaped maze (elevated ~50 cm off the ground) consisting of two
opposing open arms and two opposing closed arms, the latter of
which were enclosed by ~ 20 cm high walls. The movement within
the maze was tracked using Videotrack (Viewpoint, Champagne au
Mont d'Or, France), and the proportion of time spent in the open
arms during the 5 min test period was calculated, as described
elsewhere (Walf and Frye, 2007).2.3.4. Open ﬁeld test (OFT)
For the OFT, the locomotor activity of mice in a testing arena
(27.3 cm  27.3 cm) equipped with infrared beam arrays (Med-
Associates Inc., St. Albans, VT, USA) was evaluated for 60 min. Data
were analyzed using the software Activity Monitor (MedAssociates
Inc., St. Albans, VT, USA) to calculate the total distance travelled, as
previously described (Khan et al., 2014).2.3.5. Rotarod
In the Rotarod test the motor coordination of mice was evalu-
ated using an automated system consisting of a rotating drum and
the accompanying software (MedAssociates Inc., St. Albans, VT,
USA). During a 6-min test period the rotation speed was increased
steadily from 4 rpm to 40 rpm and the latency of the animal to fall
off the drum was recorded and averaged over three trials for each
mouse, as previously described (Khan et al., 2014).
Fig. 1. Timeline of experimental paradigm for MIA using Poly(I:C). Time points of events and procedures are shown: Mice were mated for 12 h; pregnant females were injected with
Poly(I:C) at E12.5; pups were born at approx. E19 and weaned at 4 weeks old; behavioral experiments or sacriﬁce and brain extraction were performed at the age of 8e12 weeks in
separate cohorts.
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All mice were sacriﬁced by cervical dislocation. Brains were
quickly extracted and hippocampi were bilaterally dissected from
each animal.
Western Blot experiments, mRNA analysis and chromatin
immunoprecipitation (ChIP) were carried out using tissue from
parallel cohorts of mice.
For ChIP andWestern Blot experiments, the tissue was placed in
reaction tubes, ﬂash-frozen using liquid nitrogen immediately
following dissection, and then stored at 80 C until used for
analysis. mRNA samples were stored in RNAse-free reaction tubes
containing RNAlater (Ambion, Austin, TX, USA) and stored
at 20 C for subsequent experimental work-up.
2.5. Molecular biology and biochemistry experiments
2.5.1. Western Blot analysis
Standard Western Blot analysis (Monje et al., 2011) was per-
formed on hippocampal tissue of PIC and control mice. Brieﬂy,
tissue was homogenized in 1 M PBS followed by lyzation in a
protein lysis buffer (10 mM TriseHCl pH 7.5, 150 mM NaCl, 1% SDS,
0.5% Triton X-100, 1 mM EDTA, 10 mM NaF, 5 mM Na4O2P7, 10 mM
Na3VO4 and 1 protease inhibitor cocktail (ThermoScientiﬁc,
Waltham, MA, USA)).
Protein concentration was determined using the BCA Protein
Assay Kit (Pierce Biotechnology, Rockford, IL, USA) according to the
manufacturer's instructions and using a Synergy Multi-Mode
Microplate Reader (Biotek, Winooski, VT, USA) for spectroscopic
measurements. 50 mg of total protein was mixed with 5 ml Loading
Buffer (ThermoScientiﬁc,Waltham,MA, USA) and subjected to SDS-
PAGE electrophoresis followed by blotting onto a PVDF membrane.
Membranes were incubated with primary antibodies (SERT:
1:1000, Santa Cruz, Dallas, TX, USA; b-actin: 1:2000, US Biological,
Salem, MA, USA; H3: 1:1000, Abcam, Cambridge, UK; acH3: 1:1000,
Millipore; H4: 1:1000, Millipore; acH4: 1:1000, Millipore, Billerica,
MA, USA) overnight at 4 C followed by a one-hour incubation at
room temperature (RT) with the appropriate secondary antibody
(SERT: Donkey anti-goat IgG-HRP, 1:3000, Santa Cruz, Dallas, TX,
USA; b-actin: Goat anti-mouse IgG-HRP, 1:3000, Cell Signaling
Technology; all histones: anti-rabbit IgG-HRP, 1:3000, CellSignaling Technology, Danvers, MA, USA). Pierce ECL Western Blot
Substrate (Pierce Biotechnology, Rockford, IL, USA) was used to
develop the membranes according to manufacturer's instructions.
Quantiﬁcationwas performed by chemiluminescent imagingwith a
FluorChem HD2 (Alpha Innotec, Kasendorf, Germany) using the
respective software. Values obtained from densitometry of target
proteins (SERT, acetylated H3 and H4) were normalized (b-actin for
SERT, total H3 and H4 for acetylated H3 and H4) for the semi-
quantitative determination of protein levels as described else-
where (Griesauer et al., 2014).2.5.2. RNA isolation, cDNA synthesis and qRT-PCR
mRNA was extracted using the RNEasy Mini Kit (Qiagen, Venlo,
Netherlands) according to the protocol supplied by the manufac-
turer. 900 ng of mRNAwas used for the subsequent cDNA synthesis
using the DyNAmo cDNA Synthesis Kit (ThermoScientiﬁc,Waltham,
MA, USA) following the manufacturer's instructions.
cDNA samples (dilutions: SERT and HDAC4 1:1, HDAC1 and
HDAC5 1:5, b-actin 1:10) were used for qRT-PCR assessment of the
relative levels of hippocampal mRNA and HDACs. For each sample
repeat, 7.5 ml of SYBR Green MasterMix (LifeTechnologies, Carls-
bad, CA, USA), 0.15 ml each of forward (sequences HDAC1:
CCGCATGACTCATAATTTGCTG; HDAC4: GGCCCACCGGAATCTGAAC;
HDAC5: TCTTGTCGAAGTCAAAGGAGG, Invitrogen, Waltham, MA,
USA) and reverse (sequences HDAC1: TGTGAGGGCGATAGATTTC-
CAT; HDAC4: GCTGCGTTTTCCCGTACCA; HDAC5: GAGGG-
GAACTCTGGTCCAAAG, Invitrogen, Waltham, MA, USA) primers,
6.2 ml of RNase-free water and 1 ml of sample were added to a well
of a RT-PCR plate. All reactions were carried out in duplicates. C(t)
values were obtained for each sample as well as a concomitant
determination of the housekeeping gene b-actin (sequences for-
ward: ATGGTGGGAATGGGTCAGAAG; reverse: TCTCCATGTCGTCC-
CAGTTG, Invitrogen, Waltham, MA, USA).
The C(t) values for b-actin were used for calculation of DC(t),
representing the relative quantiﬁcation of mRNA amounts in each
sample. This further allowed the calculation of DDC(t), subtracting
the mean DC(t) value of the control group from the mean DC(t)
value for the Poly(I:C) group. DDC(t) was then used to express the
fold change of mRNA levels observed between Poly(I:C)-exposed
mice and untreated mice, using the formula 2DDC(t).
Fig. 2. MIA increases anhedonic behavior in adult female offspring (PIC), but does not affect behavioral despair, anxiety-related behavior or general behavior. a. Analysis of
anhedonic behavior of control vs. PIC mice in the sucrose preference test [control n¼ 37; PIC n ¼ 15]. b. Freezing behavior of control vs. PIC mice during the forced swim test [control
n ¼ 26; PIC n ¼ 14]. c. Analysis of anxiety-related behavior of control vs. PIC mice in the elevated plus maze [control n ¼ 26; PIC n ¼ 14]. d. Total locomotor activity of control vs. PIC
mice in the open ﬁeld test [control n ¼ 26; PIC n ¼ 14]. e. Analysis of motor coordination of control vs. PIC mice in the Rotarod test [control n ¼ 26; PIC n ¼ 14]. Data are presented as
mean ± SEM; ***: p  0.001; n.s. not signiﬁcant.
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For Chromatin immunoprecipitation (ChIP) analysis of H3 and
H4 acetylation at the SERT promoter, hippocampal tissue of two
mice of the same treatment group (randomly selected acrossdifferent litters to eliminate any possible litter effects) and sex were
pooled to obtain one ChIP sample. The protocol employed was
adapted from Nelson et al. (2006).
Brieﬂy, hippocampal tissue was homogenized in 1.42%
Fig. 3. MIA alters global levels of histone acetylation in the PIC hippocampus. a. Result
of Western blot analyzing protein levels of acH3 vs. total H3 in the hippocampus of
control vs. PIC mice [control n ¼ 5; PIC n ¼ 5]. b. Result of Western blot analyzing
protein levels of acH4 vs. total H4 in the hippocampus of control vs. PIC mice [control
n ¼ 5; PIC n ¼ 5]. Data are presented as mean ± SEM (relative to controls); *: p  0.05.
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cross-linking, quenching (125 mM glycine), washing (PBS) and lysis
in low salt IP buffer with protease inhibitors (IP Buffer, low salt:
150 mM NaCl, 50 mM TriseHCl/pH 7.5, 5 mM EDTA, 0.5% NP-40, 1%
Triton X-100; Halt protease inhibitors added just prior to use in
1:100 dilution, ThermoScientiﬁc, Waltham, MA, USA). After cell
lysis, samples were centrifuged (2000 G, 4 C, 5 min), washed (low
salt IP buffer), centrifuged again and resuspended in 500 ml low salt
IP buffer. Shearing of chromatin was accomplished using a soni-
cator bath (Bioruptor Plus, Diagenode, Liege, Belgium) after which
samples were equally divided into three parts for immunoprecip-
itation with antibodies (anti-acetyl-H3, Millipore; and anti-acetyl-
H4, Millipore, Billerica, MA, USA) and mock immunoprecipitation
(without antibodies). 7 ml of antibody (anti-acH3 and anti-acH4) or
IP buffer (for mock reaction) and 20 ml of protein A magnetic beads
(Magna ChIP Protein A Magnetic Beads, Millipore, Billerica, MA,
USA) were added and samples were incubated overnight at 4 C on
a rotating platform. The following day, samples were washed and a
magnetic rack (Magna GrIP Rack, Millipore, Billerica, MA, USA) was
utilized to pellet the samples. The ﬁnal pellet was resuspended in100 ml PBS (1 M) and 1 ml of proteinase K (20 ug/ul) and incubated
for 30 min on a heated shaker (55 C) After high speed centrifu-
gation, samples were boiled at 95 C for 15 min to dissociate the
magnetic beads from the antibodies. The magnetic beads were
removed using the magnetic rack and the PCR-ready DNA samples
were transferred to new reaction tubes and stored at - 20 C until
used for qRT-PCR.
For qRT-PCR, master mixes containing SYBR Green Master Mix
(12.5 ml per sample repeat, LifeTechnologies, Carlsbad, CA, USA) and
SERT primers (4 ml each, sequences forward: CAGAGCTCT-
CAGTCTTGTCTCC; reverse: TGCTGGTCAGTCAGTGGTG; Invitrogen,
Waltham, MA, USA) were prepared and 4.5 ml of each sample was
added per reaction. All samples were analyzed in duplicates. C(t)
values for each sample and IP conditionwere recorded and used for
statistical analysis. Brieﬂy, qRT-PCR data were analyzed as
described above, except that instead of b-actin C(t) values, mock IP
C(t) values were used as internal controls, accounting for potential
differences in input tissue amounts and non-speciﬁc binding of the
magnetic beads in each IP condition.
2.6. Statistical analysis
For comparisons between two groups (PIC versus control mice)
in the behavioral and all molecular and biochemical experiments,
two-sample t-tests (two-tailed, equal variance) were carried out
and p-values  0.05 were considered statistically signiﬁcant. All
calculations were conducted using Microsoft Excel.
3. Results
3.1. Adult female PIC offspring display enhanced depression-related
anhedonia but show no alterations in behavioral despair, anxiety-
related and general behavioral functions
SPT analysis was performed in order to characterize the effect of
MIA on depression-related anhedonia in female PIC offspring as
compared to control mice. A statistically signiﬁcantly reduced su-
crose preference (p  0.001, Fig. 2a) was observed in PIC females.
No signiﬁcant difference between PIC and control mice was
observed in behavioral despair as reﬂected in the time spent
immobile during the FST (Fig. 2b). Similarly, mice from the PIC and
control groups spent comparable proportions of time in the open
arms of the EPM (Fig. 2c). Locomotor activity in the OFT, evaluated
by the total distance travelled (Fig. 2d), and motor coordination, as
measured by the latency to fall off the Rota rod (Fig. 2e), was not
signiﬁcantly different between PIC and control mice.
3.2. Acetylation of histone H3 and H4 is altered in the hippocampus
of adult female PIC offspring
In light of the relevance of epigenetic mechanisms for long-
lasting alterations in neuronal structure and function and associ-
ated mental illnesses (Tsankova et al., 2007), we next set out to
determine functionally relevant histone modiﬁcations in the hip-
pocampus of PIC and control mice. Western Blot analyses demon-
strated that the global relative level of acetylated histone H3 was
signiﬁcantly increased in hippocampal tissue of PIC mice (p  0.05,
Fig. 3a). The ratio of acetylated H4 versus total H4 was decreased in
the hippocampus of PIC mice (p  0.05, Fig. 3b).
3.3. Hippocampal HDAC1 levels are reduced in adult female PIC
offspring
Seeking to examine the molecular mediators of altered histone
acetylation patterns, levels of histone deacetylating enzymes
Fig. 4. MIA alters hippocampal mRNA levels of select HDACs in PIC mice. a. Relative mRNA level of HDAC1 in control vs. PIC mice [control n ¼ 6; PIC n ¼ 8]. b. Relative mRNA level of
HDAC4 in control vs. PIC mice [control n ¼ 6; PIC n ¼ 7]. c. Relative mRNA level of HDAC4 in control vs. PIC mice [control n ¼ 7; PIC n ¼ 7]. Data are presented as mean ± SEM
(relative to controls); **: p  0.01; n.s.: not signiﬁcant.
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control mice. Preliminary experiments (data not shown) showed
that among HDACs 1-11, only HDACs 1, 4 and 5 were expressed at
detectable levels. Hence, these HDACs were further analyzed for
potential differences between PIC and control mice. A signiﬁcant
reduction in relative levels of HDAC1 mRNA was observed in PIC
animals (p  0.05, Fig. 4a), while no differences for HDAC4 and
HDAC5 expression were found between groups (Fig. 4b, c).
3.4. Histone H3 and H4 acetylation is enhanced at the SERT
promoter in PIC offspring
In order to investigate whether global alterations in histone
acetylation proﬁle were also detectable at the promoter sites of
speciﬁc genes, Chromatin Immunoprecipitation (ChIP) analysis was
employed, focusing on SERT, given its pivotal role in the patho-
physiology of depression and therapeutic action of pharmacological
antidepressant drugs (Haase and Brown, 2014). A signiﬁcant in-
crease in acetylated H3 and H4 associated with the SERT promoter
in the hippocampus of PIC mice was revealed (p  0.05, Fig. 5a and
b).
3.5. PIC offspring display altered hippocampal SERT expression
Aiming to ascertain whether the observed modiﬁcations of
histone structures at the SERT promoter translated into alterations
in protein expression, hippocampal SERT levels were determined inPIC and control mice Indeed, Western Blots analysis revealed about
50% increase in hippocampal SERT protein in PIC as compared to
control mice (p  0.01, Fig. 5c).
4. Discussion
The presented results suggest that maternal immune activation
may exert its effect on offspring behavior via the long-term mod-
ulation of epigenetic mechanisms, which in turn can lead to alter-
ations in gene expression, in particular of SERT.
We ﬁrst conﬁrmed the effect of developmental infectious stress
exposure through MIA by the viral mimetic Poly(I:C) at E12.5 on
depression-like behavior in adult female offspring. As previously
described for male progeny (Khan et al., 2014), we also observed
enhanced anhedonic behavior in female offspring after MIA, mani-
festing in signiﬁcantly reduced sucrose preference in the SPT. In
contrast, the FST showed that - as opposed to male PIC offspring -
behavioral despair was not increased in adult female PIC offspring.
Other behavioral tests, including the OFT, EPM and Rotarod, showed
no differences in the behavior of female PIC vs. control offspring, in
line with our previous report on males (Khan et al., 2014).
While these data further support the general relevance ofMIA in
mice as a model for speciﬁc symptoms reﬂecting depressive-like
behavior, they also suggest a potential applicability of the para-
digm in the investigation of the biological basis of gender differ-
ences in depression. In humans, depression has been repeatedly
reported to affect women almost twice as often asmen (Angst et al.,
Fig. 5. MIA alters levels of histone acetylation at the hippocampal SERT promoter and increases hippocampal SERT protein in PIC mice. a. Binding of acH3 at SERT promoter in the
hippocampus of control vs. PIC mice [control n ¼ 6; PIC n ¼ 6]. b. Binding of acH4 at SERT promoter in the hippocampus of control vs. PIC mice [control n ¼ 6; PIC n ¼ 6]. c. Results of
Western blot analyzing hippocampal levels of SERT vs. actin protein in control vs PIC mice [control n ¼ 5; PIC n ¼ 7]. Data are presented as mean ± SEM (relative to controls); **:
p  0.01; *: p  0.05.
S.N. Reisinger et al. / Neurobiology of Stress 4 (2016) 34e43402002 Bebbington et al., 1998; Kuehner, 2003 Silverstein, 1999;
Weissman and Klerman, 1977). Additionally, gender differences in
symptoms associatedwith depressive episodes have been reported,
with appetite disturbances highlighted as one major difference
betweenwomen and men (Marcus et al., 2005 Romans et al., 2007;
Wenzel et al., 2005). It is plausible to speculate that altered expe-
rience of reward, which relates to anhedonia, may underlie these
gender speciﬁcities in people and are mimicked by the herein
observed sex differences in response to prenatal infectious stress in
mice. Indeed, the enhancement in anhedonic behavior in female
PIC offspring is slightly larger than the one found in males (Khan
et al., 2014). By contrast, a higher sensitivity of male rodents to
the development of behavioral despair in the FST has been
described in different animal models of depression (Alonso et al.,
1991; Gomez et al., 2014) and is thus in line with the present
ﬁndings in the PIC paradigm. Overall, these ﬁrst insights into the
sex-differences in behavioral responses to gestational infection
highlight the need for further investigations into their neurobio-
logical underpinnings and translational implications.
In an attempt to understand how gestational infection may lead
to long-term alterations in brain structure and function at themolecular, cellular and behavioral level, selected epigenetic
markers in the adult offspring brain were examined for changes
induced by MIA treatment. Epigenetic regulation of gene expres-
sion (i.e. genetic control, independent of DNA sequence) is widely
thought to represent a molecular substrate for the interaction be-
tween genes and the environment leading to long-lasting alter-
ations in transcription and persistent physiological and
pathophysiological functional consequences. Indeed, numerous
studies propose a critical role for aberrant transcriptional regula-
tion in the pathophysiology of several psychiatric disorders
including MDD (Charney et al., 2004; Krishnan and Nestler, 2008).
Recently, ﬁrst reports on the effects of prenatal infectious stress
induced by MIA on selected epigenetic markers have been
emerging (Basil et al., 2014 Connor et al., 2012; Tang et al., 2013). In
contrast to previous studies, we here focused on the global histone
acetylation proﬁle in the adult offspring hippocampus, a central
brain structure involved in the neural circuitry of MDD (McKinnon
et al., 2009; Posener et al., 2003).
In particular, acetylation of H3 and H4 histones was deemed a
suitable candidate mechanism, since it has been previously impli-
cated in the pathophysiology of MDD, as well as being proposed as
S.N. Reisinger et al. / Neurobiology of Stress 4 (2016) 34e43 41a molecular effector mediating long-lasting Gene  Environment
interactions (Liu et al., 2008; Tammen et al., 2013).
To date, most studies investigating histone acetylation in asso-
ciation with a depression-related phenotype have used stress par-
adigms during the early postnatal phase or in adulthood and have
mostly reported decreased H3 acetylation, with one study showing
an increase in H4 acetylation (reviewed in Bagot et al. (2014)). Thus
while these studies support a general relevance for H3 and H4
acetylation in the pathophysiology of depression, the particular
circumstances speciﬁcally inducing H3 and/or H4 modiﬁcationsFig. 6. Proposed model of the long-term impact of MIA on depression-related behavior an
MIA, the maternal immune reaction includes the activation of cytokines which can readily cro
transduction pathways, these cytokines are proposed to inﬂuence epigenetic mechanisms
aberrant gene expression, may also directly interfere with correct brain development. Con
which lead to long-lasting behavioral modiﬁcations in the offspring. Histone deacteylase (Hremain to be delineated as well as their respective contributions to
the etiology of depression.
With respect to MIA, there has only been one other study
investigating levels of histone acetylation: Tang et al. (2013) re-
ported no signiﬁcant effect of MIA on levels of histone acetylation in
the hippocampus in adult mice, although the group noted a trend
for reduced H4 acetylation, partially lending support to results of
the present study (Tang et al., 2013). However, the currently
available information does not yet allow for the establishment of
causal associations between the observed alterations in globald associated molecular, cellular and functional alterations in the offspring brain. Upon
ss the placental barrier into the fetal compartment. Through yet uncharacterized signal
in the long term, leading to changes in gene expression. Cytokines, together with this
sequently, important alterations at the molecular, cellular and functional levels occur
DAC); Histone acetyl transferase (HAT); DNA methyltransferase (DNMT).
S.N. Reisinger et al. / Neurobiology of Stress 4 (2016) 34e4342hippocampal H3 and H4 acetylation and the behavioral distur-
bances resulting from MIA.
Rather, they suggest the dynamic regulation of H3 and H4 acetyla-
tion in the PIC hippocampus thatmay serve as a foundation for future
in-depth investigations into the involved regulatorymechanisms.
In order to gain ﬁrst insights into the intracellular mechanism
potentially mediating the observed changes in histone acetylation in
PIC mice, we examined expression of several HDACs, which e be-
sides histone acetyl-transferases (HATs) - are considered the major
regulators of histone acetylation (Peserico and Simone, 2011). While
most HDACs (HDAC2, 3, 6, 7, 8, 9, 10, 11) were not sufﬁciently
expressed in our samples to allow pertinent analysis of their levels,
the selective reduction in HDAC1 expression observed in the PIC
hippocampus proposes this enzyme as a speciﬁc mediator of the
impact of MIA on epigenetic regulation in the offspring brain.
Interestingly, while its deﬁned role remains to be elucidated, evi-
dence for an involvement of HDAC1 in the pathophysiology of MDD
and in the effects of pharmacological antidepressant treatment has
been emerging lately from studies using various animal models
(Covington et al., 2011 Schmauss, 2015; Schroeder et al., 2013).
It is conceivable that the modulation of HDAC1 levels in the PIC
hippocampus may contribute to the observed increase in global H3
acetylation as well as the speciﬁc effects at the SERT promoter.
However, it cannot explain the decrease in H4 acetylation. In this
respect, it is important to consider that HDAC activity need not
necessarily relate to expressional levels. However, due to the lack of
commercially available speciﬁc HDAC1 activity assays one cannot yet
directly relate changes in HDAC expression to activity, far less to the
observed changes in histone acetylation and behavior in PIC mice.
Furthermore, HATsmay play just as important a role in the regulation
of histone acetylation levels and thereby gene expression e but
remaineven lesswell studied thanHDACs in thecontextofdepression
and have not yet been investigated within the MIA paradigm at all.
We next set out to explore potential gene-speciﬁc epigenetic
regulations, focusing on SERT, a key molecule involved in MDD-
related serotonergic signaling and prominent target of antide-
pressant drugs. The more than two-fold increased binding of both
acH3 and acH4 histones to the SERT promoter in the PIC hippo-
campus indicates SERT as speciﬁc target of the MIA-induced regu-
lation of the epigenetic machinery which may underlie or
contribute to the depression-like phenotype observed in MIA
offspring. At the molecular level, hippocampal SERT protein
expression was signiﬁcantly increased in the MIA-exposed group
which is in agreement with the fact that acetylation of histones has
previously been linked to enhanced gene transcription (Shahbazian
and Grunstein, 2007; Turner, 2014). However, while the focus of
this study lay on the relevance of histone acetylation, other
epigenetic mechanisms, such as DNA methylation, linked to MDD
in different contexts (Domschke et al., 2014), may also act to
regulate SERT expression. The observed increase in SERT levels in
PIC mice, which display depression-like behavior, is in agreement
with the generally held view that a reduction in SERT function
(such as during administration of an SSRI) produces an antide-
pressant effect (Haase and Brown, 2014).
5. Conclusions
The present study provides evidence for alterations in several
epigenetic processes in the adult female offspring brain resulting
from MIA and proposes altered hippocampal SERT expression as
one speciﬁc molecular effector. Furthermore, to the best of our
knowledge, this is the ﬁrst demonstration of an effect of MIA on
histone modiﬁcations speciﬁcally at the SERT promoter. While
acknowledging that other mechanisms may be involved, we pro-
pose that MIA-dependent regulation of adult hippocampal SERTexpression is e at least in part e mediated by changes in histone
(H3 and H4) acetylation at the SERT promoter. As such, this study
supports the general notion that epigenetic mechanisms contribute
to the environmental programming of brain development and
behavior by embedding the impact of early life experience on gene
expression (Fig. 6). Moreover, the speciﬁc effect on SERT, together
with the already documented involvement of SERT inMDD, suggest
that SERT holds a critical role in the development of depression-
related traits associated with early life infectious stress. In
conjunction with previous ﬁndings investigating the inﬂuence of
other exogenous adverse events at different stages of life, our data
further highlight the complexity of Gene  Environment in-
teractions involved in the development of MDD e of which MIA
constitutes one speciﬁc contributing factor.
Future analyses may build upon the data presented herein and
may yield valuable information about the temporal course of the
effect of MIA on SERT function and dependent behaviors as well as
the precise molecular pathways employed. Jointly, this information
may then allow the identiﬁcation of critical windows suitable for
the application of preventive interventions and potentially point
towards new therapeutic targets for the treatment of depression.Acknowledgments
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